Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.07 USD | -0.24% |
|
+5.78% | +2.16% |
Jul. 01 | William Blair Downgrades Amedisys to Market Perform From Outperform | MT |
Jul. 01 | Amedisys, Inc.(NasdaqGS:AMED) added to Russell 1000 Defensive Index | CI |
Evolution of the average Target Price on Amedisys, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Amedisys, Inc.
RBC Capital Markets | |
Cantor Fitzgerald | |
Deutsche Bank Securities | |
Jefferies & Co. | |
Benchmark Company | |
Truist Securities | |
Credit Suisse | |
TD Cowen | |
Barclays | |
UBS | |
Oppenheimer | |
SVB Securities LLC | |
Stephens Inc. | |
Raymond James | |
Benchmark Capital | |
Stifel Nicolaus | |
BofA Securities | |
SVB Leerink | |
BMO Capital | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- AMED Stock
- Consensus Amedisys, Inc.